A

Arecor Therapeutics plc

41 employees

Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform.

Basic info

Industry

biotechnology research

Sectors

Freedom-to-Operate (FTO) formulations
Biotechnology
Vaccine Stability
Liquid products with superior stability
High Concentration mAbs
Ready-to-Use (RTU) formats
Pharmaceutical
Lyo-to-liquid switch
IV to SQ
Education
Differentiated Biosimilars
Diabetes
Ready-to-Administer (RTA) formats
Biopharma

Date founded

2007

Funding rounds raised

Total raised

$12M

from 9 investors over 9 rounds

A

Arecor Therapeutics plc raised $3.9M on March 31, 2021

Investors: Innovate UK

A

Arecor Therapeutics plc raised $7.8M on September 10, 2018

Investors: AlbionVC

A

Arecor Therapeutics plc raised $1.3M on June 18, 2018

Investors: Innovate UK

A

Arecor Therapeutics plc raised $12M on August 3, 2016

Investors: Cambridge Angels, DSM Venturing and Unilever Ventures

A

Arecor Therapeutics plc raised undisclosed on March 5, 2013

Investors: DSM Venturing

A

Arecor Therapeutics plc raised undisclosed on January 1, 2008

Investors: Unilever Ventures and HYGEA VCT PLC

FAQ